Medical Management of Endometriosis, Present and Future with Special Reference to MHT in the Patient Previously Diagnosed with Endometriosis

Tobie J. de Villiers
In: ISGE Series · 2020 · pp. 149–157 · doi:10.1007/978-3-030-57866-4_14 · W3111476042
book-chapter OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06+body, 2026-06-08 ⓘ

This chapter aims to provide insight into hormonal treatment options for endometriosis, including their mechanisms, efficacy, and side effects, to enable individualized patient care.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 ⓘ

This paper/chapter reviews medical management options for endometriosis, focusing on hormonal treatments by describing their mechanisms of action, efficacy, and side-effect profiles, and emphasizing treatment individualization for people with endometriosis. It defines endometriosis as endometrial-like tissue outside the uterus that triggers chronic inflammation and notes that it is chronic and incurable, with associated pain and infertility. A major caveat explicitly stated is that adenomyosis is acknowledged but not specifically addressed. This paper is centrally about endometriosis — it is a chapter on medical management of endometriosis with special reference to menopausal hormone therapy (MHT) in patients previously diagnosed with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK